Neuros Medical Inc has secured $20m in a series AA Financing round led by US Venture Partners.

The US-based company plans to use the funds to progress its IDE clinical study.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Evolent Health Inc has announced a public offering of seven million class A common stock shares priced at $24.1 each to raise $175m.

"Osprey plans to use the stocks to invest in research and development (R&D) and for marketing of its products."

Located in the US, Evolent plans to use funds to purchase class A common shares.

US-based company Osprey Medical Inc has announced the private placement of 27 million common stock shares priced at A$0.4 ($0.32) each to raise A$22.18m ($17.61m).

Osprey plans to use the stocks to invest in research and development (R&D) and for marketing of its products.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact